loader
Please Wait
Applying Filters...

Suanfarma Suanfarma

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_2013_079___rev_00 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Cipla

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Inke S.A: APIs manufacturing plant.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 CIPLA LIMITED Mumbai IN (1)

    filter

    01 Nevirapine hemihydrate (1)

    filter

    01 India (1)

    filter

    01 Withdrawn by Holder (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    CIPLA LIMITED Mumbai IN

    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag India
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Nevirapine hemihydrate

    PDF Supplier PDF
    URL Supplier Web Content
    R1-CEP 2013-079 - Rev 00
    Withdrawn by Holder
    Chemical
    2018-09-10
    2022-05-13
    2479
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2013-079 - Rev 00 of Cipla Limited Mumbai In

    Looking for Certificates of Suitability (CEPs) for R1-CEP 2013-079 - Rev 00 of Cipla Limited Mumbai In 1

    20

    Cipla Limited Mumbai In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their significant offerings is Nevirapine hemihydrate, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2013-079 - Rev 00

    This Chemical Type CEP, issued on September 10, 2018, remains in force until May 13, 2022, ensuring its reliability within the pharmaceutical industry.

    Substance Number 2479 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY